For example, triple-negative breast cancers (TNBC) exhibit enhanced epithelial-mesenchymal transition (EMT), increased expression of SOX2 and CXCR4, and an ability to cross the blood–brain barrier, contributing to their high affinity for brain tissue12. This evidence concerns the gene CXCR4 and triple-negative breast carcinoma.